Type We interferon (IFN-I) signaling is a central pathogenic pathway in Systemic Lupus Erythematosus (SLE), and therapeutics targeting IFN-I signaling are in advancement. the advertising of autoimmunity16C18, developing interest has devoted to distributed signaling pathways including phosphorylation of STAT family. Cytosolic STATs are turned on through receptor ligation and following tyrosine phosphorylation by Janus family… Continue reading Type We interferon (IFN-I) signaling is a central pathogenic pathway in